- call +1-201-465-4211
- email sales@mrinsights.biz
Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
Scope of the Report:
This report studies the Prostate Cancer Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer Testing market by product type and applications/end industries.
The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
There are many new drugs that have increased the life expectancy of prostate cancer patients and have been approved by the Food & Drug Administration. But these drugs are having a high cost, which is a threat for the patients and the insurers, both. These expensive drugs are not being paid by the insurance companies and the reimbursement level for them is very low. Hence, only few people are capable of affording these drugs. Therefore, because of this high cost, the use of generic drugs is more, and hence, it is hindering the growth of the prostate cancer drugs market.
North America is the leading global market with the largest revenue share in 2017. Due to the rising prevalence of the diseases and high mortality rate of the prostate cancer in the United States, North America is dominating the market. Asia-Pacific is also projected to be the fastest growing region due to the improving healthcare infrastructure and the growing investments by the key market players.
The global Prostate Cancer Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others
Market Segment by Applications, can be divided into
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Prostate Cancer Testing Market Overview
1.1 Product Overview and Scope of Prostate Cancer Testing
1.2 Classification of Prostate Cancer Testing by Types
1.2.1 Global Prostate Cancer Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Prostate Cancer Testing Revenue Market Share by Types in 2017
1.2.3 PSA Tests
1.2.4 CTC Tests
1.2.5 Immunohistochemistry
1.2.6 PCA3 Tests
1.2.7 Others
1.3 Global Prostate Cancer Testing Market by Application
1.3.1 Global Prostate Cancer Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Associated Labs
1.3.3 Independent Diagnostic Laboratories
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Global Prostate Cancer Testing Market by Regions
1.4.1 Global Prostate Cancer Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Prostate Cancer Testing (2013-2023)
2 Manufacturers Profiles
2.1 Genomic Health
2.1.1 Business Overview
2.1.2 Prostate Cancer Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genomic Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 OPKO
2.2.1 Business Overview
2.2.2 Prostate Cancer Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 OPKO Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Siemens Healthcare
2.3.1 Business Overview
2.3.2 Prostate Cancer Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Siemens Healthcare Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 DiaSorin
2.4.1 Business Overview
2.4.2 Prostate Cancer Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 DiaSorin Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 bioMeriux
2.5.1 Business Overview
2.5.2 Prostate Cancer Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 bioMeriux Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Prostate Cancer Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 MDx Health
2.7.1 Business Overview
2.7.2 Prostate Cancer Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 MDx Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Beckman Coulter
2.8.1 Business Overview
2.8.2 Prostate Cancer Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Beckman Coulter Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Myriad Genetics
2.9.1 Business Overview
2.9.2 Prostate Cancer Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Myriad Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ambry Genetics
2.10.1 Business Overview
2.10.2 Prostate Cancer Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ambry Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Prostate Cancer Testing Market Competition, by Players
3.1 Global Prostate Cancer Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate Cancer Testing Players Market Share
3.2.2 Top 10 Prostate Cancer Testing Players Market Share
3.3 Market Competition Trend
4 Global Prostate Cancer Testing Market Size by Regions
4.1 Global Prostate Cancer Testing Revenue and Market Share by Regions
4.2 North America Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
4.5 South America Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
5 North America Prostate Cancer Testing Revenue by Countries
5.1 North America Prostate Cancer Testing Revenue by Countries (2013-2018)
5.2 USA Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
6 Europe Prostate Cancer Testing Revenue by Countries
6.1 Europe Prostate Cancer Testing Revenue by Countries (2013-2018)
6.2 Germany Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
6.3 UK Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
6.4 France Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Prostate Cancer Testing Revenue by Countries
7.1 Asia-Pacific Prostate Cancer Testing Revenue by Countries (2013-2018)
7.2 China Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
7.5 India Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
8 South America Prostate Cancer Testing Revenue by Countries
8.1 South America Prostate Cancer Testing Revenue by Countries (2013-2018)
8.2 Brazil Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Prostate Cancer Testing by Countries
9.1 Middle East and Africa Prostate Cancer Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Prostate Cancer Testing Revenue and Growth Rate (2013-2018)
10 Global Prostate Cancer Testing Market Segment by Type
10.1 Global Prostate Cancer Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Prostate Cancer Testing Market Forecast by Type (2018-2023)
10.3 PSA Tests Revenue Growth Rate (2013-2023)
10.4 CTC Tests Revenue Growth Rate (2013-2023)
10.5 Immunohistochemistry Revenue Growth Rate (2013-2023)
10.6 PCA3 Tests Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 Global Prostate Cancer Testing Market Segment by Application
11.1 Global Prostate Cancer Testing Revenue Market Share by Application (2013-2018)
11.2 Prostate Cancer Testing Market Forecast by Application (2018-2023)
11.3 Hospital Associated Labs Revenue Growth (2013-2018)
11.4 Independent Diagnostic Laboratories Revenue Growth (2013-2018)
11.5 Cancer Research Institutes Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global Prostate Cancer Testing Market Size Forecast (2018-2023)
12.1 Global Prostate Cancer Testing Market Size Forecast (2018-2023)
12.2 Global Prostate Cancer Testing Market Forecast by Regions (2018-2023)
12.3 North America Prostate Cancer Testing Revenue Market Forecast (2018-2023)
12.4 Europe Prostate Cancer Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Prostate Cancer Testing Revenue Market Forecast (2018-2023)
12.6 South America Prostate Cancer Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Prostate Cancer Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Prostate Cancer Testing Picture
Table Product Specifications of Prostate Cancer Testing
Table Global Prostate Cancer Testing and Revenue (Million USD) Market Split b
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
